From: Role of protein tyrosine phosphatase receptor type M in epithelial ovarian cancer progression
Factors | β | SE | HR (95% CI) | P-value |
---|---|---|---|---|
PTPRM | -1.559 | 1.024 | 0.210(0.028,1.565) | 0.128 |
Age | 1.113 | 0.557 | 3.042(1.020,9.072) | 0.046 |
CA125 | 1.517 | 0.436 | 4.559(1.94,10.716) | 0.001 |
Clinical stages | 2.567 | 0.626 | 13.022(3.821,44.379) | < .0001 |
Ascites | 1.232 | 0.621 | 3.428(1.015,11.571) | 0.047 |
Tumor diameter | -0.734 | 0.434 | 0.480(0.205,1.124) | 0.091 |
Family history | 0.561 | 0.484 | 1.752(0.679,4.521) | 0.246 |
Age of menostasis | -0.228 | 0.461 | 0.796(0.323,1.964) | 0.620 |
Age of menarche | 0.475 | 0.427 | 1.607(0.697,3.709) | 0.266 |
Comorbidities | 0.288 | 0.441 | 1.334(0.563,3.164) | 0.513 |
HE4 | 1.529 | 0.514 | 4.613(1.686,12.622) | 0.003 |
CA19-9 | -0.932 | 0.510 | 0.394(0.145,1.069) | 0.068 |
Lymphatic metastasis | 1.638 | 0.456 | 5.144(2.106,12.566) | < 0.001 |